Table 3 Effect of metformin with different durations on blood biochemistry
From: Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes
Variables | Duration (<1 year) | Duration (>1 year) | P value | ||
|---|---|---|---|---|---|
Mean ± SD | N | Mean ± SD | N | ||
Blood glucose (mmol/L) | 6.45 ± 1.00 | 71 | 6.35 ± 0.95 | 41 | 0.6092 |
Systolic blood pressure (mmHg) | 132.21 ± 9.76 | 71 | 135.17 ± 13.35 | 41 | 0.1807 |
Diastolic blood pressure (mmHg) | 73.56 ± 6.89 | 71 | 73.90 ± 7.86 | 41 | 0.8122 |
Hemoglobin A1c (%) | 6.39 ± 0.56 | 71 | 6.41 ± 0.59 | 41 | 0.8255 |
Body mass index | 25.51 ± 3.04 | 71 | 25.93 ± 4.53 | 41 | 0.5601 |
Total cholesterol (mmol/L) | 4.81 ± 1.44 | 71 | 4.55 ± 0.87 | 41 | 0.3038 |
Triglyceride (mmol/L) | 1.12 ± 0.34 | 71 | 2.09 ± 1.49 | 41 | 0.0400 |
HDL (mmol/L) | 1.12 ± 0.34 | 36 | 1.15 ± 0.23 | 23 | 0.7767 |
LDL (mmol/L) | 2.65 ± 0.83 | 71 | 2.69 ± 0.81 | 41 | 0.7920 |
VLDL (mmol/L) | 0.83 ± 0.39 | 36 | 0.77 ± 0.44 | 23 | 0.5596 |
Creatinine (μmol/L) | 80.75 ± 15.11 | 71 | 86.95 ± 20.59 | 41 | 0.0703 |